| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 95.1K | $3.31M | $34.85 | 20 Jun 2025 | Direct |
| Roivant Sciences Ltd. | Director | Common Shares | 109K | $1.93M | $17.74 | 20 Oct 2025 | Direct |
| Roivant Sciences Ltd. | Director | Stock Option (Right to Buy) | 33.7K | 10 Sep 2025 | Direct | ||
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 8.43K | 20 Jun 2025 | Direct | ||
| PRA Health Sciences, Inc. | Director | Common Stock | 0 | $169.75 | 01 Jul 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 20 Oct 2025 | 2 | -$2.8K | 4 | Director | 22 Oct 2025, 21:01 |
| ROIV | Roivant Sciences Ltd. | 10 Sep 2025 | 3 | -$45.2K | 4 | Director | 12 Sep 2025, 21:00 |
| ROIV | Roivant Sciences Ltd. | 17 Jul 2025 | 2 | -$2.81K | 4 | Director | 21 Jul 2025, 21:00 |
| BBIO | BridgeBio Pharma, Inc. | 20 Jun 2025 | 2 | $0 | 4 | Director | 24 Jun 2025, 18:57 |
| ROIV | Roivant Sciences Ltd. | 17 Apr 2025 | 2 | -$2.8K | 4 | Director | 21 Apr 2025, 21:00 |
| ROIV | Roivant Sciences Ltd. | 23 Jan 2025 | 2 | -$3.43K | 4 | Director | 27 Jan 2025, 21:00 |
| ROIV | Roivant Sciences Ltd. | 21 Oct 2024 | 1 | $0 | 4 | Director | 23 Oct 2024, 21:00 |
| ROIV | Roivant Sciences Ltd. | 12 Sep 2024 | 1 | -$37K | 4 | Director | 16 Sep 2024, 21:00 |
| ROIV | Roivant Sciences Ltd. | 10 Sep 2024 | 2 | $0 | 4 | Director | 12 Sep 2024, 21:00 |
| ROIV | Roivant Sciences Ltd. | 23 Jul 2024 | 1 | $0 | 4 | Director | 25 Jul 2024, 21:00 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 17:39 |
| ROIV | Roivant Sciences Ltd. | 24 Apr 2024 | 2 | -$3.19K | 4 | Director | 26 Apr 2024, 21:01 |
| ROIV | Roivant Sciences Ltd. | 19 Jan 2024 | 1 | $0 | 4 | Director | 23 Jan 2024, 21:00 |
| ROIV | Roivant Sciences Ltd. | 16 Oct 2023 | 2 | -$7.08K | 4 | Director | 18 Oct 2023, 21:30 |
| ROIV | Roivant Sciences Ltd. | 18 Sep 2023 | 1 | -$75.4K | 4 | Director | 20 Sep 2023, 22:33 |
| ROIV | Roivant Sciences Ltd. | 12 Sep 2023 | 2 | $0 | 4 | Director | 14 Sep 2023, 22:31 |
| ROIV | Roivant Sciences Ltd. | 03 Jul 2023 | 1 | $0 | 4 | Director | 06 Jul 2023, 21:30 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:22 |
| ROIV | Roivant Sciences Ltd. | 03 Apr 2023 | 1 | $0 | 4 | Director | 05 Apr 2023, 21:31 |
| ROIV | Roivant Sciences Ltd. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 20:30 |
| ROIV | Roivant Sciences Ltd. | 31 Oct 2022 | 1 | $0 | 4 | Director | 02 Nov 2022, 17:57 |
| ROIV | Roivant Sciences Ltd. | 15 Sep 2022 | 2 | $0 | 4 | Director | 19 Sep 2022, 21:53 |
| ROIV | Roivant Sciences Ltd. | 20 Jul 2022 | 1 | $0 | 4 | Director | 25 Jul 2022, 06:06 |
| BBIO | BridgeBio Pharma, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:32 |
| BBIO | BridgeBio Pharma, Inc. | 29 Dec 2021 | 1 | $1.16M | 4 | Director | 03 Jan 2022, 18:47 |
| ROIV | Roivant Sciences Ltd. | 01 Oct 2021 | 0 | $0 | 3 | Director | 01 Oct 2021, 17:41 |
| MAAC | Montes Archimedes Acquisition Corp | 30 Sep 2021 | 0 | $0 | 4 | Chief Executive Officer, Director, 10%+ Owner | 04 Oct 2021, 17:13 |
| PRAH | PRA Health Sciences, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 17:36 |
| BBIO | BridgeBio Pharma, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 19:21 |
| PRAH | PRA Health Sciences, Inc. | 01 Jun 2021 | 1 | $0 | 4 | Director | 03 Jun 2021, 16:04 |